ImmunityBio (IBRX) Interest & Investment Income (2015 - 2021)
ImmunityBio (IBRX) posted quarterly Interest & Investment Income of $112000.0 for Q2 2021, up 333.33% year-over-year from $25846.2 in Q2 2020, and down 98.75% quarter-over-quarter from $8.9 million in Q1 2021.
Powered by 
Analysis
ImmunityBio (IBRX) Interest & Investment Income (2015 - 2021) Analysis & Trends
ImmunityBio (IBRX) has reported Interest & Investment Income for 7 consecutive years, with $112000.0 the latest figure, recorded in Q2 2021.
- In Q2 2021, Interest & Investment Income rose 333.33% year-over-year to $112000.0; the TTM figure through Jun 2021 stood at $9.6 million (up 1127.78% YoY), while the FY2020 annual figure was $1.2 million, down 24.95% from the prior year.
- Interest & Investment Income retreated to $112000.0 in Q2 2021 per IBRX's latest filing, from $8.9 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $8.9 million in Q1 2021 and bottomed at -$5.0 million in Q4 2017.
- Historically, Interest & Investment Income has averaged $585611.1 across 5 years, with a median of $440000.0 in 2018.
- Annual changes were most pronounced in 2017 — Interest & Investment Income slumped 609.93% — and 2021, when it jumped 11366.67%.
- ImmunityBio's Interest & Investment Income stood at -$5.0 million in 2017, then jumped by 117.48% to $875000.0 in 2018, then slumped by 63.66% to $318000.0 in 2019, then soared by 187.42% to $914000.0 in 2020, then plunged by 87.75% to $112000.0 in 2021.
- Business Quant data shows IBRX's Interest & Investment Income at $112000.0 in Q2 2021, $8.9 million in Q1 2021, and $914000.0 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 10.98 Mn |
| 10 | ImmunityBio | 8.48 Bn | 8.12 Bn | 50.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 112,000.00 |
| Mar 31, 2021 | 8.94 Mn |
| Dec 31, 2020 | 438,000.00 |
| Sep 30, 2020 | 449,000.00 |
| Jun 30, 2020 | 341,000.00 |
| Mar 31, 2020 | 78,000.00 |
| Dec 31, 2019 | 307,000.00 |
| Sep 30, 2019 | 433,000.00 |
| Jun 30, 2019 | 533,000.00 |
| Mar 31, 2019 | 410,000.00 |
| Dec 31, 2018 | 495,000.00 |
| Sep 30, 2018 | 486,000.00 |
| Jun 30, 2018 | 632,000.00 |
| Mar 31, 2018 | 704,000.00 |
| Dec 31, 2017 | 817,000.00 |
| Sep 30, 2017 | 1.01 Mn |
| Jun 30, 2017 | 1.05 Mn |
| Mar 31, 2017 | 1.35 Mn |
| Dec 31, 2016 | 1.37 Mn |
| Sep 30, 2016 | 1.37 Mn |